
|Articles|November 1, 2012
Greater knowledge of B cell autoimmunity allows for specific targeting
As research continues to explore B cell autoimmunity, B cell-mediated therapies likely will pursue increasingly specific targets, says Arthur Kavanaugh, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
3
Clinicians See Intersection of Weight Loss and Facial Aging
4
Top 5 Articles of the Week: January 11-16
5


















